FluxMPS™ RPMI 1640 Medium: 1X Liquid

Product#: DCP-RPMI1X
$34.10
DCP-RPMI1X
Availability:
Ships in 1-2 Weeks

warning For Research Use Only (RUO). Not intended for clinical, diagnostic, or therapeutic use in humans.
verified ISO 13485 Certified Manufacturing

FluxMPS™ RPMI 1640

Contains L-Glutamine Contains Sodium Bicarbonate Contains Phenol Red Contains Calcium Contains Magnesium Contains Glucose Contains Sodium Pyruvate

FluxMPS™ DCP-RPMI1X is a Microfluidics Suitable, quadruple-stage ultra-filtered RPMI 1640 formulation engineered for hematopoietic and lymphocyte cell models on organ-on-a-chip (OoC) and microphysiological system (MPS) platforms. Processed through a quadruple-stage filtration system (0.1 µm ×2 + 0.04 µm ×2), it reaches a 0.04 µm final cut-off — five times finer than the 0.22 µm membranes used for conventional sterile filtration. Formulation: [+] 2 g/L Glucose, [+] L-Glutamine, [+] Sodium Pyruvate, [+] Sodium Bicarbonate, [+] Phenol Red.

  • Glucose source: 2000 mg/L (2.0 g/L), formulated for lymphocyte and hematopoietic cell metabolism
  • Glutathione (reduced), 1.0 mg/L — antioxidant support for redox-sensitive immune cell types
  • Quadruple-stage filtration train: 0.1 µm → 0.04 µm → 0.1 µm → 0.04 µm, reaching a 0.04 µm final cut-off
  • Endotoxin release specification: < 0.05 EU/mL (LAL assay, USP <85>)
  • Sodium bicarbonate–buffered (2000 mg/L); formulated for 5% CO₂ incubation
  • Manufactured under an ISO 13485:2016 quality management system; final QC at Diagnocine, Totowa, NJ
  • Phenol red–containing (5.3 mg/L) formulation — red-colored, clear solution
  • Available in 500 mL and 1000 mL packs; custom formulation available on request
CAT. NO.
DCP-RPMI1X | Cell Culture Media UNSPSC: 41116155 | Commodity: Molecular biology and cell culture growth media | (UNv260801)
RPMI 1640 — 1X Liquid
  • Media familyRPMI 1640
  • Glucose2000 mg/L (2.0 g/L)
  • Formulation[+] L-Glutamine, [+] Sodium Bicarbonate, [+] Phenol Red, [+] Calcium, [+] Magnesium, [+] Glucose, [+] Sodium Pyruvate
  • pH (USP <791>)7.4
  • Osmolality (USP <785>)Contact for specification
  • Endotoxin (USP <85>)< 0.05 EU/mL
  • Filtration0.1 µm ×2 + 0.04 µm ×2 (Quadruple-stage)
  • Storage2–8°C, away from light
  • Shelf Life12 months from date of manufacture, unopened
  • ShippingCold pack (2–8°C)
ISO 13485:2016 USP <85> <785> <788> RUO
Why FluxMPS™

Engineered where standard media fails

Conventional 0.22 µm–filtered RPMI passes mycoplasma-sized particulates and subvisible aggregates that can confound sensitive immune cell assays. FluxMPS™ is built around a finer, four-stage filtration architecture to address these failure modes.

filter_alt

Microchannel-safe purity

0.04 µm final filtration with USP <788> Method 1 particulate compliance. An ultra-low particulate baseline suited to suspension immune cell OoC and flow cytometry workflows.

science

Immune cell–optimized formulation

RPMI 1640 contains glutathione (antioxidant) plus higher phosphate, inositol, and choline than DMEM — a profile developed for lymphocyte and hematopoietic cell culture.

water_drop

Ultrapure-grade water

Type 1 water, 18.2 MΩ·cm, manufactured under tight trace-metal and organic-carbon (TOC) control.

visibility

Low background for imaging

0.04 µm filtration provides an ultra-low particulate baseline suited to confocal microscopy and biosensor-integrated OoC platforms.

analytics

Rich nutrient profile

A full RPMI 1640 amino acid, vitamin, and glutathione profile, delivered particle-free for demanding immune cell OoC applications.

tune

Customization on demand

pH, nutrient concentrations, HEPES, and component modifications available. Contact support@diagnocine.com.

Purity Architecture

Quadruple-stage filtration system

Four serial filtration stages — two paired prefilter + final-filter passes — reaching a final 0.04 µm polish.

  1. 1

    0.1 µm Prefiltration I — Large Particulate Removal

    Removes large aggregates and cell debris; protects the first 0.04 µm cartridge.

  2. 2

    0.04 µm Final filtration I — Mycoplasma-Retentive Barrier

    First 0.04 µm pass; retains mycoplasma-sized particulates (0.2–0.3 µm) and sub-micron aggregates that pass a standard 0.22 µm filter.

  3. 3

    0.1 µm Prefiltration II

    A second, dedicated prefilter protecting the second 0.04 µm cartridge.

  4. 4

    0.04 µm Final filtration II — Polish

    Ultimate polishing filter; ISO Class 5 (Class 100) aseptic fill & finish.

Performance vs. conventional media

A quadruple-stage train (0.1 µm ×2 + 0.04 µm ×2) reaches a 0.04 µm final cut-off, five times finer than the 0.22 µm membranes used for conventional sterile filtration.

5×
Finer pore size (0.04 µm) than conventional 0.22 µm–filtered media
0.04
µm final pore size — quadruple-stage terminal filtration
Sterility & Mycoplasma: No growth after 14-day incubation (USP <71>). Mycoplasma control is achieved through 0.1 µm and 0.04 µm mycoplasma-retentive filtration at every production stage (not tested per lot).
Grade: This product is Microfluidics Suitable, filtered to a 0.04 µm final cut-off. It is not an MPS Grade product — that designation is reserved for the 0.01 µm ultra nano-filtered line, which adds 0.02 µm and 0.01 µm stages after the 0.04 µm polish. For applications requiring the 0.01 µm cut-off, contact support@diagnocine.com.
FluxMPS™ RPMI 1640 Medium (DCP-RPMI1X) quadruple-stage filtration system, 0.1 micron times two plus 0.04 micron times two final filtration for organ-on-a-chip, microfluidic, and immune cell OoC applications, Diagnocine
Figure 1. FluxMPS™ quadruple-stage filtration system (0.1 µm ×2 + 0.04 µm ×2) applied to DCP-RPMI1X RPMI 1640 medium.
© Diagnocine® — DCP-RPMI1X
Applications

Immune cell OoC and hematopoietic applications

FluxMPS™ DCP-RPMI1X — RPMI 1640 — delivers 0.04 µm filtered, Microfluidics Suitable purity for hematopoietic and lymphocyte cell OoC applications.

Automated Bioreactors & Robotics

Next-Generation System Uptime

Optional 0.01 µm (10 nm) MPS Grade variant available on request for automated perfusion systems.

  • Total Particulate Exclusion: 10 nm filtration removes nanoparticulate aggregates
  • Valve & Sensor Protection: Reduces micro-fouling risk in automated perfusion systems
  • Extended Perfusion Stability: Consistent nutrient delivery over long-duration culture

Inquiry Required: Contact support@diagnocine.com for the 0.01 µm MPS Grade variant.

Immunology

T Cell & Lymphocyte Culture

RPMI 1640 is the standard base for primary T cells, B cells, NK cells, and monocytes. 0.04 µm filtration provides an ultra-low particulate baseline for immune assays.

T cellsB cellsNK cellsPBMC
Cancer Biology

Leukemia & Lymphoma Lines

RPMI supports NCI-60 cancer lines, Jurkat, Raji, K562, HL-60, and hematopoietic cancer lines where DMEM would alter proliferation and signaling.

JurkatRajiK562HL-60
Microfluidics

Immune Cell OoC

0.04 µm filtered RPMI for tumor-immune interaction chips, vascular-immune OoC, and lymph node-on-chip models.

Tumor-immune chipLymph node OoCMPS
Immunotherapy

CAR-T & TIL Expansion

Endotoxin release specification < 0.05 EU/mL supports CAR-T manufacturing and TIL expansion protocols sensitive to LPS-driven activation.

CAR-TTILTCR-T
Metabolomics

Immune Cell Metabolic Flux

Defined RPMI base supports ¹³C isotope tracing and NMR-based metabolomics of lymphocyte activation states. Not compatible with Agilent Seahorse XF assays, which require bicarbonate-free, phenol red–free medium.

¹³C tracingNMR metabolomicsGlycolysis
Live-Cell Imaging

Flow Cytometry & Confocal

0.04 µm filtered RPMI provides an ultra-low particulate baseline for flow cytometry and confocal imaging of immune cells. A phenol red–free RPMI variant is available on request for autofluorescence-sensitive fluorescence assays.

Flow cytometryConfocalELISA
Technical Specifications

Analytical release specifications

Every lot released against the full specification matrix. CoA: support@diagnocine.com.

Physical & Chemical Parameters
Parameter Specification
Formulation [+] L-Glutamine, [+] Sodium Bicarbonate, [+] Phenol Red, [+] Calcium, [+] Magnesium, [+] Glucose (2 g/L), [+] Sodium Pyruvate
Appearance Red-colored, clear solution
Glucose 2000 mg/L (2.0 g/L)
pH USP <791> 7.4
Osmolality USP <785> Contact for specification
Total ingredients 41 components across 4 categories
Sterility, Purity & Safety
Parameter Specification
Endotoxin USP <85> BET < 0.05 EU/mL
Sterility USP <71> No growth / 14 days
Mycoplasma 0.1 µm / 0.04 µm mycoplasma-retentive filtration (not tested per lot)
Particulate ≥10 µm USP <788> Method 1 NMT 25/mL
Particulate ≥25 µm USP <788> Method 1 NMT 3/mL
Water purity Type 1, 18.2 MΩ·cm
Manufacturing std. ISO 13485:2016
Fill environment ISO Class 5 (Class 100)
Storage, Handling & Logistics
Parameter Specification
Storage temperature 2–8°C, away from light
Freeze-thaw Do not freeze
Shelf life 12 months from date of manufacture, unopened
Shipping condition Cold pack
CO₂ requirement 5% CO₂ required (sodium bicarbonate buffered)
Raw Materials & Regulatory Traceability
Parameter Specification
Raw material grade Reagent / cell culture grade
Traceability Full lot traceability per ISO 13485
Manufacturing QMS ISO ISO 13485:2016 certified
UNSPSC 41116155 — Molecular biology and cell culture growth media (UNv260801)
Regulatory alignment 21 CFR Part 820 (QMSR) aligned
Production method Micro-batch, per-lot QC release
Intended use Research Use Only (RUO)
Available pack sizes 500 mL, 1000 mL
Formulation

Full composition (mg/L)

RPMI 1640: 41 ingredients verified per lot with CAS numbers for full raw-material traceability. RPMI 1640 contains glutathione (antioxidant) and a balanced profile of vitamins and amino acids optimized for lymphocyte and hematopoietic cell culture.

Component CAS Number mg/L
INORGANIC SALTS
Calcium nitrate tetrahydrate 13477-34-4 100.000
Magnesium sulfate anhydrous 7487-88-9 48.840
Potassium chloride 7447-40-7 400.000
Sodium bicarbonate 144-55-8 2000.000
Sodium chloride 7647-14-5 6000.00
Sodium phosphate dibasic anhydrous 7558-79-4 800.000
Component CAS Number mg/L
AMINO ACIDS
Glycine 56-40-6 10.000
L-Arginine hydrochloride 1119-34-2 241.000
L-Asparagine 70-47-3 50.000
L-Aspartic acid 56-84-8 20.000
L-Cystine dihydrochloride 30925-07-6 65.200
L-Glutamic acid 56-86-0 20.000
L-Glutamine 56-85-9 300.000
L-Histidine hydrochloride monohydrate 5934-29-2 20.960
L-Hydroxyproline 51-35-4 20.000
L-Isoleucine 73-32-5 50.000
L-Leucine 61-90-5 50.000
L-Lysine hydrochloride 657-27-2 40.000
L-Methionine 63-68-3 15.000
L-Phenylalanine 63-91-2 15.000
L-Proline 147-85-3 20.000
L-Serine 56-45-1 30.000
L-Threonine 72-19-5 20.000
L-Tryptophan 73-22-3 5.000
L-Tyrosine Disodium Salt 69847-45-6 28.830
L-Valine 72-18-4 20.000
Component CAS Number mg/L
VITAMINS
Choline chloride 67-48-1 3.000
D-Biotin 58-85-5 0.200
D-Ca-Pantothenate 137-08-6 0.250
Folic acid 59-30-3 1.000
Niacinamide 98-92-0 1.000
Pyridoxine hydrochloride 58-56-0 1.000
Riboflavin 83-88-5 0.200
Thiamine hydrochloride 67-03-8 1.000
Vitamin B12 68-19-9 0.005
i-Inositol 87-89-8 35.000
p-Amino benzoic acid (PABA) 150-13-0 1.000
OTHERS
D-Glucose 50-99-7 2000.000
Glutathione reduced 70-18-8 1.000
Phenol red sodium salt 34487-61-1 5.300
Sodium Pyruvate 113-24-6 110.000
Custom formulation: Contact support@diagnocine.com for DCP-RPMI1X modifications.
Quality Assurance

Manufacturing & compliance

Every FluxMPS™ product is manufactured and released under a multi-layer quality system.

verified

ISO 13485:2016 Quality Management

Manufactured under an ISO 13485:2016-certified quality management system. Final QC at Diagnocine, Totowa, NJ, USA.

water_drop

Ultrapure Type 1 Water

18.2 MΩ·cm feed water, manufactured under tight trace-metal and organic-carbon (TOC) control.

biotech

ISO Class 5 Fill & Finish

Aseptic fill in validated ISO Class 5 (Class 100) laminar-flow workstations.

assignment

Micro-Batch Precision

Small-batch, per-lot tested — Certificate of Analysis available for every batch.

Endotoxin — USP <85> BET

LAL assay; release specification < 0.05 EU/mL; assay sensitivity 0.005 EU/mL.

Particulate — USP <788> Method 1

≤25/mL (≥10 µm), ≤3/mL (≥25 µm), light obscuration.

Osmolality — USP <785>

Target: Contact for specification.

Documentation & CoA

Full CoA with raw-material traceability available on request.

Batch-level quality control. Endotoxin is controlled per manufacturing batch rather than per unit. Every batch is tested before release and must meet the release specification:
  • Endotoxin — LAL assay, USP <85> Bacterial Endotoxins Test; assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL
  • pH, osmolality, conductivity, appearance and clarity
  • Sterility
A Certificate of Analysis is available on request at support@diagnocine.com.
Product Comparison

How DCP-RPMI1X compares

FluxMPS™ DCP-RPMI1X vs. conventional 0.22 µm–filtered RPMI 1640 and published supplier specifications.

Parameter DCP-RPMI1X (FluxMPS™) Comparison
Grade Microfluidics Suitable Standard grade (0.22 µm filtered)
RPMI 1640 full formulation with glutathione, 2 g/L glucose check_circle Yes Varies by supplier
Final filtration pore size 0.04 µm 0.22 µm (typical)
Number of filtration stages 4 (Quadruple-stage) 1 (typical)
Mycoplasma-retentive filtration check_circle Yes (0.1 / 0.04 µm) cancel Not typically stated
Endotoxin (release specification) < 0.05 EU/mL Corning classical liquid media — < 0.25 EU/mL
Sigma-Aldrich DMEM complete medium — ≤ 2 EU/mL
Gibco classical DMEM — Not specified (recorded per lot)
USP <788> particulate compliance check_circle Yes (Method 1) cancel Not specified
Water quality Type 1, 18.2 MΩ·cm Purified water (typical)
Manufacturing QMS ISO 13485:2016 ISO 9001 or none (typical)
Microfluidic channel compatibility check_circle Yes cancel Risk of clogging
Custom formulation available check_circle Yes cancel Not typically offered

Comparison figures from published supplier specifications, accessed 2026-09-02. Suppliers that publish no numeric endotoxin specification are shown as "Not specified".

FAQ

Frequently asked questions

Common questions about FluxMPS™ DCP-RPMI1X — RPMI 1640.

Yes. DCP-RPMI1X is processed through a quadruple-stage filtration system reaching a 0.04 µm final pore size, delivering an ultra-low particulate baseline for immune cell OoC, tumor-immune interaction chips, and lymphocyte perfusion models. It is Microfluidics Suitable at this 0.04 µm cut-off; the separate 0.01 µm MPS Grade line is available on request for automated bioreactor and robotics applications.
FluxMPS™ uses four sequential filters — 0.1 µm prefiltration I, 0.04 µm final filtration I, 0.1 µm prefiltration II, and 0.04 µm final filtration II (polish) — reaching a 0.04 µm final cut-off, five times finer than the 0.22 µm membranes used in conventional filtration.
RPMI 1640 (Roswell Park Memorial Institute Medium) was developed for human leukocyte culture. Compared to standard DMEM, RPMI has lower glucose (2 g/L vs 4.5 g/L) and higher phosphate, inositol, and choline — nutrients important for rapidly dividing lymphocytes — and contains glutathione for antioxidant support. RPMI is the standard base for T cells, B cells, NK cells, monocytes, leukemia/lymphoma lines, and NCI-60 cancer cell lines.
Yes. This formulation is buffered with 2000 mg/L sodium bicarbonate and is formulated for 5% CO₂ incubation to maintain pH 7.4.
Yes. FBS (5–10%), serum-free supplements, growth factors, or antibiotics may be added. When adding serum or other protein-containing supplements, filter through a 0.2 µm low-protein-binding PES or PVDF membrane — never 0.04 µm, which retains serum proteins and lipoproteins. Contact support@diagnocine.com for custom co-formulation.
Endotoxin is controlled per manufacturing batch to a release specification of < 0.05 EU/mL, verified by LAL assay (USP <85>, assay sensitivity 0.005 EU/mL) before release. A Certificate of Analysis is available on request.
Yes. Each batch's CoA covers appearance, pH (USP <791>), osmolality (USP <785>), sterility (USP <71>), endotoxin (USP <85>), mycoplasma-retentive filtration status, particulate count (USP <788> Method 1), and raw-material traceability. Request at support@diagnocine.com.
Scientific References

Supporting literature

Key publications supporting RPMI 1640 in immune cell culture and OoC applications.

  1. Moore GE, et al. Culture of normal human leukocytes. JAMA. 1967;199:519–524. doi:10.1083/jcb.1.3.273
  2. Huh D, et al. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662–1668. doi:10.1126/science.1188302
  3. Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32:760–772. doi:10.1038/nbt.2989
  4. Novak R, et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020;4:407–420. doi:10.1038/s41551-019-0497-x
  5. Jang KJ, et al. Human kidney proximal tubule-on-a-chip. Integr Biol. 2013;5:1119–1129. doi:10.1039/c3ib40049b
  6. Schimek K, et al. Integrating biological vasculature into a multi-organ-chip microsystem. Lab Chip. 2013;13:3588–3598. doi:10.1039/c3lc50217a
  7. Luni C, et al. High-efficiency cellular reprogramming with microfluidics. Nat Methods. 2016;13:446–452. doi:10.1038/nmeth.3832
  8. Sung JH, et al. Microfabricated mammalian organ systems. Lab Chip. 2013;13:1201–1212. doi:10.1039/c3lc41017j

Satisfaction
Quality Rating
Value Rating
Style Rating
X